亚托皮炎治疗:对传统和新型生物工程方法的全面审查
Narges Elahi1, Mohammad Ebrahim Astaneh2, Jafar Ai3
1Student Research Committee, Fasa University of Medical Sciences, Fasa, Iran; Department of Tissue Engineering, School of Advanced Technologies in Medicine, Fasa University of Medical Sciences, Fasa, Iran.
International journal of biological macromolecules
|November 8, 2024
概括
新型生物材料和干细胞为亚托皮性皮炎 (AD) 治疗提供了有前途的进展,解决了传统疗法的局限性. 这些创新方法为管理这种具有挑战性的皮肤状况提供了增强的药物输送和生物相容性.
科学领域:
- 生物医学工程 生物医学工程
- 皮肤病学 皮肤病学
- 材料科学 材料科学 材料科学
背景情况:
- 亚托皮炎 (AD) 由于常规治疗的局限性,包括不良影响和低于最佳的疗效,因此存在重大治疗挑战.
- 现有的治疗方法,如光疗和湿疗法已经证明有用,但具有固有的局限性.
- 迫切需要先进和有效的治疗策略来管理亚托邦性皮肤炎.
研究的目的:
- 审查目前的亚托皮性皮炎治疗方式,重点关注传统方法,新型疗法和新兴的生物工程策略.
- 探索补充和替代疗法的潜力,特别是功能化生物材料和干细胞,用于AD管理.
- 突出先进生物材料在开发下一代皮肤病治疗方法的优势,如AD.
主要方法:
- 对亚托皮性皮肤炎的现有和新兴治疗方法的综合文献综述.
- 分析常规疗法,包括药物管理,光疗和湿疗法.
- 探索新的方法,如向生物制剂,功能化生物材料 (例如原体,PCL,PLGA),基于纳米技术的疗法和干细胞应用.
主要成果:
- 传统的治疗方法往往需要高剂量或频繁的使用,导致副作用和有效性有限.
- 有针对性的生物药物显示出希望,而光疗和湿疗法具有特定的局限性.
- 功能化生物材料和干细胞代表了新一代治疗选择,有可能改善生物相容性,生物降解性和受控的药物释放.
结论:
- 先进的生物材料和干细胞疗法作为阿托皮性皮肤炎的有效辅助治疗具有显著的前景.
- 生物材料的独特特性,包括生物相容性和受控的药物释放,比传统方法提供了显著的优势.
- 对这些创新策略的进一步研究对于开发用于亚托皮炎的现代和有效治疗方法至关重要.
相关概念视频
Clinical Applications of Epidermal Stem Cells
2.7K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.7K
Inflammatory Bowel Disease IV: Pharmacological Management
114
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
114


